Literature DB >> 29699174

Activation of protein kinase C inhibits the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages.

Hisashi Narahara1, Hiroko Utsunomiya1, Masakazu Nishida1, Kaei Nasu1, Yasushi Kawano1, Isao Miyakawa1.   

Abstract

Background and Aims:  Platelet activating factor (PAF), a potent phospholipid mediator, has been implicated in a number of reproductive processes through ovulation to parturition. To clarify the regulatory mechanism of PAF metabolism in the decidua, we have investigated the effect of activation of protein kinase C (PKC) on the secretion of PAF-acetylhydrolase (PAF-AH), a PAF-inactivating enzyme, by human decidual macrophages.
Methods:   Decidual macrophage populations were isolated from human decidua by using enzymic digestion, Ficoll-Paque centrifugation, or flow cytometric sorting. The cells were treated with a PKC activator (TPA), H-7, dibutyryl cyclic adenosine monophosphate (AMP), Bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid, tetra (acetoxymethyl)-ester (BAPTA/AM) and/or nifedipine. The activity of PAF-AH secreted in the culture medium was assayed.
Results:   The PKC activator, TPA, inhibited the PAF-AH secretion by decidual cells in a dose-dependent manner. The TPA also decreased the enzyme secretion by flow cytometrically purified macrophages. The inhibitory effect of TPA was blocked by a PKC inhibitor, H-7. Protein kinase A (PKA) activation by dibutyryl cyclic AMP was without effect on the enzyme secretion. Calcium channel blockers, BAPTA/AM and nifedipine had no effect on the PAF-AH secretion.
Conclusion:   It is suggested that the TPA-induced inhibition of PAF-AH secretion may be mediated, in part, by a PKC-dependent signal transduction, and that activation of PKC may result in the increase in the local concentration of PAF in the decidua because of its inhibitory effect on the PAF-AH secretion by decidual macrophages. (Reprod Med Biol 2003; 2: 121-126).

Entities:  

Keywords:  decidua; parturition; platelet‐activating factor acetylhydrolase; protein kinase C; signal transduction

Year:  2003        PMID: 29699174      PMCID: PMC5907122          DOI: 10.1046/j.1445-5781.2003.00032.x

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  19 in total

1.  Effects of platelet-activating factor on prostaglandin E2 production by intact fetal membranes.

Authors:  C Morris; H Khan; M H Sullivan; M G Elder
Journal:  Am J Obstet Gynecol       Date:  1992-04       Impact factor: 8.661

2.  Platelet-activating factor induces an imbalance between matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 expression in human uterine cervical fibroblasts.

Authors:  T Sugano; K Nasu; H Narahara; Y Kawano; Y Nishida; I Miyakawa
Journal:  Biol Reprod       Date:  2000-03       Impact factor: 4.285

Review 3.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

Review 4.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

5.  Inhibition of connexin43 gap junctional intercellular communication by TPA requires ERK activation.

Authors:  R J Ruch; J E Trosko; B V Madhukar
Journal:  J Cell Biochem       Date:  2001 Jun 26-Jul 25       Impact factor: 4.429

Review 6.  Studies and perspectives of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

Review 7.  Platelet-activating factor and related lipid mediators.

Authors:  S M Prescott; G A Zimmerman; D M Stafforini; T M McIntyre
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

8.  The inhibitory effect of 1,25-dihydroxyvitamin D3 on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages.

Authors:  H Narahara; I Miyakawa; J M Johnston
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

9.  Mass spectrometric evidence for the presence of platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid during labor.

Authors:  J Nishihira; T Ishibashi; Y Imai; T Muramatsu
Journal:  Lipids       Date:  1984-12       Impact factor: 1.880

10.  Identification of phospholipid platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine.

Authors:  M M Billah; J M Johnston
Journal:  Biochem Biophys Res Commun       Date:  1983-05-31       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.